Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation
Open Access
- 1 May 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Research
- Vol. 15 (5), 325-335
- https://doi.org/10.1038/sj.cr.7290301
Abstract
Using two-colour flow cytometry >200 antibodies submitted to the 8th International Workshop of Human Leukocyte Differentiation Antigens (HLDA8) have been analyzed for their reactivity with resting and activated CD203c+ basophils. Four antibodies either non-reactive or weakly reactive with resting basophils exhibited an increased reactivity with basophils activated by anti-IgE-mediated cross-linking of the high affinity IgE receptor (FcεRI). These include antibodies against CD164 (WS-80160, clone N6B6 and WS-80162, clone 67D2), as well as two reagents with previously unknown specificities that were identified as CD13 (WS-80274, clone A8) and CD107a (WS-80280, clone E63-880). The activation patterns followed either the “CD203c-like” or “CD63-like” activation profile. The CD203c profile is characterized by a rapid and significant upregulation (of CD13, CD164, and CD203c), reaching maximum levels after 5-15 min of stimulation. The phosphoinositide-3-kinase (PI3K)-specific inhibitor wortmannin inhibited the upregulation of these markers whereas 12-O-tetradecanoyl-phorbol-13-acetate (TPA) induced a rapid and FcεRI-independent upregulation within 1-2 min. In the CD63 profile, maximum upregulation (of CD63 and CD107a) was detected only after 20-40 min, and upregulation by TPA reached maximum levels after 60 min. In summary, our data identify CD13, CD107a, and CD164 as novel basophil-activation antigens. Based on time kinetics of upregulation, we hypothesize that molecules of the “CD203c group” and the “CD63 group” are linked to two different mechanisms of basophil activation.Keywords
This publication has 45 references indexed in Scilit:
- Effects of Prostaglandin D2and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by BasophilsThe Journal of pharmacology and experimental therapeutics, 2004
- The Basophil-Specific Ectoenzyme E-NPP3 (CD203c) as a Marker for Cell Activation and Allergy DiagnosisInternational Archives of Allergy and Immunology, 2004
- CD63 expression on basophils as a tool for the diagnosis of pollen‐associated food allergy: sensitivity and specificityClinical and Experimental Allergy, 2003
- Marked improvement of the basophil activation test by detecting CD203c instead of CD63Clinical and Experimental Allergy, 2003
- Individual Hymenoptera Venom Compounds Induce Upregulation of the Basophil Activation Marker Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 (CD203c) in Sensitized PatientsInternational Archives of Allergy and Immunology, 2002
- Mass, charge, and subcellular localization of a unique secretory product identified by the basophil-specific antibody BB1Journal of Allergy and Clinical Immunology, 2001
- Flow cytometric monitoring of allergen induced basophil activationCytometry, 1995
- The phenotype of human eosinophils, basophils, and mast cellsJournal of Allergy and Clinical Immunology, 1994
- The riddle of the mast cell: kit(CD117)-ligand as the missing link?Immunology Today, 1994
- Flow cytometric evaluation of human basophilsCytometry, 1993